June 11th, 2013

To meet the needs of men affected by cancer, Movember is proud to announce our donation of $6.2 million to the LIVESTRONG Foundation.

Movember Supports LIVESTRONG Foundation Cancer Services with $6.2 Million Grant
Where The Money Goes
3 MIN READ
In an effort to meet the needs of men who have been affected by cancer, Movember is proud to support our men’s health partner, the LIVESTRONG Foundation, which will allocate the $6.2 million grant over four years to expand its cancer support services to develop a prostate and testicular cancer program. To help those affected by male cancers this program will provide a single, national point of contact that will allow men and their loved ones to access a variety of support services.Thank you to all the Mo Bros and Mo Sistas that have made this donation possible.

LIVESTRONG FOUNDATION ANNOUNCES $6.2 MILLION MOVEMBER GRANT TO OFFER MORE SUPPORT SERVICES
HELPING MEN AFFECTED BY CANCER 


LOS ANGELES — June 12, 2013The LIVESTRONG Foundation has received $6.2 million from its partner Movember, the global men’s health charity that asks men to grow a moustache for 30 days each November, while women support the efforts, to raise funds and awareness for cancers affecting men. The LIVESTRONG Foundation will allocate the $6.2 million over four years to expand its cancer support services to develop a male-specific program helping those affected by prostate and testicular cancer.

“The LIVESTRONG Foundation is incredibly grateful to Movember for their generous funding that will allow us to expand our reach to men affected by prostate and testicular cancer,” said Doug Ulman, LIVESTRONG Foundation President and CEO and three-time cancer survivor.  “With one out of every two men projected to receive a cancer diagnosis in their lifetime, this funding comes at a critical time. We plan to put it to use immediately to improve the lives of men facing cancer today.”

The expanded program will meet the needs of men who have been affected by cancer, and their caregivers, family and friends. Through this program, men will have a single, national point of contact that will allow them and their loved ones to access a variety of support services. 

This program will:

  • Provide free online and phone support services, staffed by trained, bilingual patient navigators and social workers to help men and their loved ones 
  • Provide in-person patient navigators in Austin and Chicago
  • Match those affected with a peer who has been through a similar cancer experience
  • Connect men to the clinical trials in which they are eligible
  • Help men access fertility preservation services and the funds to help pay for them
  • Help men learn how to communicate with their children and loved ones about their diagnosis
  • Provide one-on-one counseling services and access to support groups for those affected by the disease
  • Allow men and their loved ones to access answers to questions about treatment options, side effects, and medical information
  • In partnership with the Patient Advocate Foundation, provide a first-of-its-kind financial assistance program for patients who have radiation co-payments associated with the treatment of their prostate cancer. 

The Foundation’s cancer support services are available in English and Spanish, and can be accessed in-person in Austin, Texas, and Chicago and via telephone (877-889-6016), and online at www.LIVESTRONG.org/GetHelp. This program will help those affected by cancer make well-informed treatment decisions and understand the options available to them. To learn more about the LIVESTRONG Foundation’s cancer support services visit, LIVESTRONG.org/GetHelp. 

 

Prostate cancer is the second-leading cause of cancer death for men in the United States and currently affects more than two million American men. One in six men will be diagnosed with prostate cancer in their lifetime. 

Testicular cancer is the most common cancer in American males between the ages of 15 and 35. It is also one of the most curable forms of cancer because treatment is so successful.